Glucagon-Like Peptide-1 Utilization Following Withdrawal of Medicaid Coverage for Weight Loss
This cross-sectional study uses data from Medicaid State Drug Utilization Data to examine associations of coverage withdrawal with Medicaid beneficiaries’ utilization of weight loss–approved glucagon-like peptide-1s.
Authors
- Bryant Shuey (ORCID: https://orcid.org/0000-0002-4846-5742)
- Timothy S. Anderson (ORCID: https://orcid.org/0000-0002-5384-275X)
- James Frank Wharam (ORCID: https://orcid.org/0000-0003-2053-0757)
- Elizabeth Nguyen
- Jing Luo
Institutions
- University of Pittsburgh (US)
- Duke University (US)
- VA Pittsburgh Healthcare System (US)
- Center for Healthcare Evaluation, Research, and Promotion (US)
- Geisinger Commonwealth School of Medicine (US)
Publication Details
- Journal
- JAMA
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1001/jama.2026.22008
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00